Royalty Pharma
RPRX
C$50.91
Share price
1.06%
Change (1 day)
28.02%
Change (1 year)
Categories
Operating Margin for Royalty Pharma (RPRX)
Operating Margin as of July 2025 (TTM): 89.01%
According to Royalty Pharma's latest financial reports and stock price the company's current Operating Margin is 89.01%. At the end of 2024 the company had an Operating Margin of 58.79%.
Operating Margin history for Royalty Pharma from 2019 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 58.79% | -18.57% |
| 2023 | 72.20% | 602.14% |
| 2022 | 10.28% | -81.03% |
| 2021 | 54.21% | -32.4% |
| 2020 | 80.19% | -40.89% |
| 2019 | 135.67% | 60.43% |
| 2018 | 84.57% | 0.6% |
| 2017 | 84.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | -4.08% | -104.58% | 🇺🇸 USA |
 Abbott Laboratories ABT | 17.36% | -80.50% | 🇺🇸 USA |
 Eli Lilly LLY | 27.75% | -68.82% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.